SCHEMBL9736669

SCHEMBL9736669

CC(C)(C(=O)O)c1ccc(CCC(O)COc2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 3/20 0.51
RXRB P28702 3/20 0.51
NR4A2 P43354 1/20 0.51
PLA2G4B P0C869 1/20 0.48
POLB P06746 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPK1 P28482 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
ABCB1 P08183 2/20 0.42
AR P10275 1/20 0.41
S1PR1 P21453 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lifibrol SCHEMBL9478310 0.90 NR4A2 (0.64) RXRARXRBNR4A2PLA2G4BPOLB
Lifibrol SCHEMBL140583 0.90 NR4A2 (0.64) RXRARXRBNR4A2PLA2G4BPOLB
Lifibrol SCHEMBL9484778 0.90 NR4A2 (0.64) RXRARXRBNR4A2PLA2G4BPOLB
SCHEMBL9384511 0.81 PLA2G4B (0.48) RXRARXRBNR4A2PLA2G4BPOLB
SCHEMBL9738348 0.81 GAA (0.49) LMNAMAPTCA12CA1CA2
SCHEMBL24464736 0.79 RXRA (0.78) RXRARXRBNR4A2PLA2G4BPOLB
SCHEMBL9485011 0.79 CA1 (0.52) RXRARXRBNR4A2LMNAMAPT
SCHEMBL10820832 0.79 CA1 (0.52) RXRARXRBNR4A2LMNAMAPT
Terbufibrol SCHEMBL2733943 0.78 NR4A2 (0.67) RXRARXRBNR4A2PLA2G4BPOLB
SCHEMBL10820851 0.77 NR1H4 (0.58) RXRARXRBNR4A2POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153353-A Antilipemic agents KLINGE PHARMA GMBH (DE) 1992-10-06 US disclosed